Cannella, Laura, et al. “Safety and Efficacy of Nilotinib in Chronic Phase Chronic Myeloid Leukemia in a Patient With Wolf-Parkinson-White Disease and Hematological Resistance After Suboptimal Response to Imatinib at Six Months”. Acta Oncologica, vol. 49, no. 3, Jan. 2010, pp. 399-00, doi:10.3109/02841860903521129.